4basebio announces plans to spin-off DNA business

The Genomics and DNA manufacturing business will remain based in the UK

picture of

Breaking News

Watson-Marlow to open ISO 14644-1 Class 7 cleanroom

The facility at the site in Cork is currently in development and will be validated to ISO 9001 Quality Management ...

Thermo Fisher Scientific and Innoforce join forces

The two companies have partnered to establish a biologics and sterile drug manufacturing facility in China

VMIC chooses BES to help with fast-tracked vaccine facility

Boulting has been chosen to fit out a new facility for the not for profit organisation established to provide the UK's ...

Drug delivery device design: supporting the success of next-generation biologics

The pressure on healthcare systems caused by ageing populations, a rise in chronic conditions and, now, the pandemic, ...

Scenic Biotech enters into genetic modifier collaboration with Genentech

Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease ...

DCprime and Glycotope to advance cancer vaccination and therapeutic antibody platforms

DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno- ...

Immunotherapy: antibody drug conjugates from a small molecule perspective

Immunotherapies such as ADCs deliver a more targeted treatment against cancer that improves the quality of life for the ...

T-knife and Catalent Sign to collaborate on autologous T-cell receptor-based cell therapy

Under the terms of the agreement, Catalent will undertake transfer of T-knife´s platform process for T-cell receptor- ...

Moderna and Chiesi establish collaboration for mRNA therapeutics

Moderna will receive $25m upfront and is eligible for more than $400m in development, regulatory, and commercial ...

Coronavirus: Frontrunners approach end of Phase III trials

Pfizer and BioNTech have recently revealed promising data showing their vaccine candidate is 90% effective

Developing innovative antivirals for novel viruses

Since the emergence of COVID-19, researchers worldwide have striven to study and overcome this new disease and the ...

From the lab to the last mile: optimising the pharma cold chain (part II)

With more than 40 COVID-19 vaccines in human testing worldwide and an expected 14 billion vaccines needed to facilitate ...

ERS Genomics signs deal with Applied StemCell

ERS Genomics holds an exclusive worldwide license from Dr Charpentier to the foundational patents covering CRISPR/Cas9

CombiGene and CGT Catapult collaborate on assays for CG01

CombiGene will now integrate the analytical assays into its production process